{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:42:43Z","timestamp":1792658563838,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2023B03J1243"],"award-info":[{"award-number":["2023B03J1243"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2023B01J1011"],"award-info":[{"award-number":["2023B01J1011"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2023-PT320-03"],"award-info":[{"award-number":["2023-PT320-03"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024A1515013289"],"award-info":[{"award-number":["2024A1515013289"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170384"],"award-info":[{"award-number":["82170384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370383"],"award-info":[{"award-number":["82370383"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.hrthm.2025.06.023","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T19:33:34Z","timestamp":1750448014000},"page":"2836-2844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of oral anticoagulant therapy on adverse outcomes in patients with atrial fibrillation after intracranial hemorrhage"],"prefix":"10.1016","volume":"22","author":[{"given":"Wulamiding","family":"Kaisaier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaokun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1280-0158","authenticated-orcid":false,"given":"Wengen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2025.06.023_bib1","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.06.023_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.06.023_bib3","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.06.023_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020040","article-title":"Atrial fibrillation in spontaneous intracerebral hemorrhage, Dijon Stroke registry (2006\u20132017)","volume":"10","author":"Gabet","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2025.06.023_bib5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1474-4422(24)00037-1","article-title":"Secondary stroke prevention in people with atrial fibrillation: treatments and trials","volume":"23","author":"Seiffge","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hrthm.2025.06.023_bib6","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/STROKEAHA.116.013343","article-title":"Anticoagulant-associated intracranial hemorrhage in the era of reversal agents","volume":"48","author":"Steiner","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2025.06.023_bib7","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/jamaneurol.2021.0925","article-title":"Association between intracerebral hemorrhage and subsequent arterial ischemic events in participants from 4 population-based cohort studies","volume":"78","author":"Murthy","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.hrthm.2025.06.023_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/practneurol-2015-001104","article-title":"Antithrombotic treatment and intracerebral haemorrhage: between Scylla and Charybdis","volume":"15","author":"Hofmeijer","year":"2015","journal-title":"Pract Neurol"},{"key":"10.1016\/j.hrthm.2025.06.023_bib9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S1474-4422(21)00264-7","article-title":"Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial","volume":"20","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hrthm.2025.06.023_bib10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S1474-4422(21)00298-2","article-title":"Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (Apache-AF): a randomised, open-label, phase 2 trial","volume":"20","author":"Schreuder","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hrthm.2025.06.023_bib11","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1161\/STROKEAHA.122.038752","article-title":"Effectiveness and safety of antithrombotic medication in patients with atrial fibrillation and intracranial hemorrhage: systematic review and meta-analysis","volume":"53","author":"Ivany","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2025.06.023_bib12","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S1474-4422(23)00315-0","article-title":"Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials","volume":"22","author":"Al-Shahi","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hrthm.2025.06.023_bib13","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0140-6736(25)00333-2","article-title":"Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial","volume":"405","author":"Veltkamp","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2025.06.023_bib14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0140-6736(25)00366-6","article-title":"Towards definitive evidence about anticoagulation for atrial fibrillation after intracranial haemorrhage","volume":"405","author":"Salman","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2025.06.023_bib15","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.06.023_bib16","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.06.023_bib17","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 10: Analysing data and undertaking meta-analyses","author":"Deeks","year":"2024"},{"key":"10.1016\/j.hrthm.2025.06.023_bib18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.06.023_bib19","series-title":"Non-vitamin K oral anticoagulants in intracerebral hemorrhage survivors with atrial fibrillation: primary results of the NASPAF-ICH randomized trial","author":"Shoamanesh","year":"2020"},{"key":"10.1016\/j.hrthm.2025.06.023_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031506","article-title":"Efficacy and safety of low-dose edoxaban by body weight in very elderly patients with atrial fibrillation: a subanalysis of the randomized ELDERCARE-AF trial","volume":"13","author":"Akao","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2025.06.023_bib43","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1212\/WNL.0000000000004235","article-title":"Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation","volume":"89","author":"Korompoki","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.hrthm.2025.06.023_bib21","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/CIRCULATIONAHA.115.019794","article-title":"Use of oral anticoagulants for stroke prevention in patients with atrial fibrillation who have a history of intracranial hemorrhage","volume":"133","author":"Chao","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.06.023_bib22","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/STROKEAHA.116.012945","article-title":"Use of antithrombotic therapy and long-term clinical outcome among patients surviving intracerebral hemorrhage","volume":"47","author":"Ottosen","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2025.06.023_bib23","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jama.2015.0846","article-title":"Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage","volume":"313","author":"Kuramatsu","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2025.06.023_bib24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ana.25079","article-title":"Oral anticoagulation and functional outcome after intracerebral hemorrhage","volume":"82","author":"Biffi","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.hrthm.2025.06.023_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejim.2019.12.016","article-title":"Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy","volume":"75","author":"Franco","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.hrthm.2025.06.023_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad226","article-title":"Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal","volume":"25","author":"Lip","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.06.023_bib27","article-title":"Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper","volume":"26","author":"Potpara","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.06.023_bib28","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left atrial appendage closure after ablation for atrial fibrillation","volume":"392","author":"Wazni","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.06.023_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.06.023_bib30","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.06.023_bib31","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2025.06.023_bib32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/europace\/euz258","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update","volume":"22","author":"Glikson","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.06.023_bib33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/14779072.2018.1510316","article-title":"Antithrombotic strategies after interventional left atrial appendage closure: an update","volume":"16","author":"Chen","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.hrthm.2025.06.023_bib34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/STROKEAHA.116.014643","article-title":"Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation","volume":"48","author":"Pennlert","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2025.06.023_bib35","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/europace\/euaa423","article-title":"Antithrombotic therapy for stroke prevention in patients with atrial fibrillation who survive an intracerebral haemorrhage: results of an EHRA survey","volume":"23","author":"Ivany","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.06.023_bib36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jacasi.2024.11.008","article-title":"Outcomes of reinitiating direct oral anticoagulants after intracranial hemorrhage: a sequential target trial emulation study","volume":"5","author":"Wu","year":"2025","journal-title":"JACC Asia"},{"key":"10.1016\/j.hrthm.2025.06.023_bib37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jacasi.2024.12.007","article-title":"Balancing risks and timing: reinitiating DOACs after intracranial hemorrhage in atrial fibrillation patients","volume":"5","author":"Lee","year":"2025","journal-title":"JACC Asia"},{"key":"10.1016\/j.hrthm.2025.06.023_bib38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.hrthm.2025.06.023_bib39","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.hrthm.2025.06.023_bib40","first-page":"575","article-title":"Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms","volume":"34","author":"Petrie","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hrthm.2025.06.023_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.959285","article-title":"Hypertension as a risk factor for atherosclerosis: cardiovascular risk assessment","volume":"9","author":"Poznyak","year":"2022","journal-title":"Front Cardiovasc Med"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125026025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125026025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:03:42Z","timestamp":1778868222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527125026025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1547527125026025"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.06.023","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of oral anticoagulant therapy on adverse outcomes in patients with atrial fibrillation after intracranial hemorrhage","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}